ZBH vs. LMAT
Compare and contrast key facts about Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ZBH or LMAT.
Performance
ZBH vs. LMAT - Performance Comparison
Returns By Period
In the year-to-date period, ZBH achieves a -6.54% return, which is significantly lower than LMAT's 83.60% return. Over the past 10 years, ZBH has underperformed LMAT with an annualized return of 1.34%, while LMAT has yielded a comparatively higher 32.31% annualized return.
ZBH
-6.54%
6.31%
-4.64%
2.05%
-3.23%
1.34%
LMAT
83.60%
15.20%
30.68%
96.22%
25.56%
32.31%
Fundamentals
ZBH | LMAT | |
---|---|---|
Market Cap | $21.79B | $2.32B |
EPS | $5.24 | $1.81 |
PE Ratio | 20.89 | 57.05 |
PEG Ratio | 1.43 | 2.32 |
Total Revenue (TTM) | $7.60B | $213.03M |
Gross Profit (TTM) | $5.03B | $142.62M |
EBITDA (TTM) | $2.36B | $60.59M |
Key characteristics
ZBH | LMAT | |
---|---|---|
Sharpe Ratio | 0.10 | 2.90 |
Sortino Ratio | 0.28 | 4.01 |
Omega Ratio | 1.04 | 1.50 |
Calmar Ratio | 0.05 | 4.15 |
Martin Ratio | 0.17 | 22.01 |
Ulcer Index | 13.06% | 4.39% |
Daily Std Dev | 21.03% | 33.40% |
Max Drawdown | -65.03% | -75.69% |
Current Drawdown | -32.97% | -1.85% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between ZBH and LMAT is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
ZBH vs. LMAT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ZBH vs. LMAT - Dividend Comparison
ZBH's dividend yield for the trailing twelve months is around 0.85%, more than LMAT's 0.46% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Zimmer Biomet Holdings, Inc. | 0.85% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% | 0.78% | 0.86% |
LeMaitre Vascular, Inc. | 0.46% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% | 1.83% | 1.50% |
Drawdowns
ZBH vs. LMAT - Drawdown Comparison
The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum LMAT drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for ZBH and LMAT. For additional features, visit the drawdowns tool.
Volatility
ZBH vs. LMAT - Volatility Comparison
The current volatility for Zimmer Biomet Holdings, Inc. (ZBH) is 8.04%, while LeMaitre Vascular, Inc. (LMAT) has a volatility of 10.37%. This indicates that ZBH experiences smaller price fluctuations and is considered to be less risky than LMAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ZBH vs. LMAT - Financials Comparison
This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities